Delivery of natural products via polysaccharide-based nanocarriers for cancer therapy: A review on recent advances and future challenges
- 25 August 2024
- journal article
- review article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 278 (Pt 4) , 135072
Abstract
No abstract availableKeywords
Funding Information
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
This publication has 228 references indexed in Scilit:
- Anticancer and chemopreventive potential of Morinda citrifolia L. bioactive compounds: A comprehensive updatePhytotherapy Research, 2024
- The anti-proliferative effects of a frankincense extract in a window of opportunity phase ia clinical trial for patients with breast cancerBreast Cancer Research and Treatment, 2024
- Luteolin, a flavone ingredient: Anticancer mechanisms, combined medication strategy, pharmacokinetics, clinical trials, and pharmaceutical researchesPhytotherapy Research, 2023
- (Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapyMedicinal Research Reviews, 2023
- Exploring the potential of quercetin/aspirin-loaded chitosan nanoparticles coated with Eudragit L100 in the treatment of induced-colorectal cancer in ratsDrug Delivery and Translational Research, 2023
- Polysaccharide‐Based Stimulus‐Responsive Nanomedicines for Combination Cancer ImmunotherapySmall, 2023
- Thermosensitive and mucoadhesive hydrogel containing curcumin-loaded lipid-core nanocapsules coated with chitosan for the treatment of oral squamous cell carcinomaDrug Delivery and Translational Research, 2022
- Genetically Engineered Viral Vectors and Organic‐Based Non‐Viral Nanocarriers for Drug Delivery ApplicationsAdvanced Healthcare Materials, 2022
- Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain routeDrug Delivery and Translational Research, 2020
- A novel strategy for glioblastoma treatment combining alpha-cyano-4-hydroxycinnamic acid with cetuximab using nanotechnology-based delivery systemsDrug Delivery and Translational Research, 2020